(Q39212216)

10 September 2017

title

Gamma-irradiation induces HER-2/neu overexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab (English)

1 reference

10 September 2017

1 reference

Ioannis F Voutsas

1

1 reference

10 September 2017

Louisa G Mahaira

2

1 reference

10 September 2017

Katerina Fotopoulou

3

1 reference

10 September 2017

Nikiforos Kapranos

4

1 reference

10 September 2017

John G Reclos

5

1 reference

10 September 2017

Angelos D Gritzapis

6

1 reference

10 September 2017

Michail Papamichail

7

1 reference

10 September 2017

Sonia A Perez

8

1 reference

10 September 2017

Constantin N Baxevanis

9

1 reference

10 September 2017

publication date

1 February 2013

1 reference

International Journal of Radiation Biology

10 September 2017

published in

1 reference

10 September 2017

volume

89

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

319-325

1 reference

NF-kappa B-mediated adaptive resistance to ionizing radiation

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Evolving novel anti-HER2 strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2013.765617

10.3109/09553002.2013.765617

21 January 2018

Identifiers

DOI

1 reference

release_io4aqt6w4zfw3jb5zcvneodmde

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/io4aqt6w4zfw3jb5zcvneodmde

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference